Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
antidiabetic/illamående
Länken sparas på Urklipp
Sida 1 från 208 resultat
Lixisenatide Therapy in Older Patients With Type 2 Diabetes Inadequately Controlled on Their Current Antidiabetic Treatment: The GetGoal-O Randomized Trial.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
To evaluate the efficacy and safety of lixisenatide versus placebo on glycemic control in older patients with type 2 diabetes uncontrolled on their current antidiabetic treatment.
In this phase III, double-blind, randomized, placebo-controlled, two-arm, parallel-group, multicenter trial, patients
[Dyspeptic syndrome associated with antidiabetic therapy].
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Dyspeptic syndrome is a common complication of treatment with antidiabetic drugs. This may be a trivial as well as a very serious complication. Nausea, vomiting, diarrhoea, abdominal pain, loss of appetite and taste disturbances are the most common symptoms of dyspeptic problems in patients treated
Pilot study of prescription-event monitoring in Japan comparing troglitazone with alternative oral hypoglycemics.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
To examine adverse events reported in a pilot study of the prescription-event monitoring in Japan (J-PEM) scheme, comparing troglitazone with other oral hypoglycemics.
METHODS
We used a cohort study with a concurrent control in which information was gathered from both doctors and
Hypoglycemic coma with ketoacidosis in nondiabetic alcoholics.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Five nondiabetic, chronically alcoholic patients presented in a comatose state during a two month prospective study and were found to be ketoacidotic. All of the patients were men, 28 to 59 years old. The usual history was one of chronic heavy, daily alcohol consumption until one to three days
[Further results of a multi-centre clinical trial with the oral antidiabetic drug glisoxepide (author's transl)].
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The oral antidiabetic agent 1-(hexahydro-1-H-azepin-1-yl)-3-(p-[2-(5-methyl-isoxazol-3-carboxamido)-ethyl]-phenylsulfonyl)-urea (glisoxepide, BS 4231, Pro-Diaban¿) was studied in a multi-centre open clinical trial comprising 4337 patients and was found to be an effective therapeutic agent for
Efficacy and safety comparison of add-on therapy with liraglutide, saxagliptin and vildagliptin, all in combination with current conventional oral hypoglycemic agents therapy in poorly controlled Chinese type 2 diabetes.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
To compare the efficacy and safety of adding liraglutide, saxagliptin and vildagliptin to current therapy in Chinese type 2 diabetes subjects with poor glycemic control.A 24-week, randomized, open-label, parallel clinical trial was performed. A total 178 patients completed the trial who had been
Adding liraglutide to oral antidiabetic drug therapy: onset of treatment effects over time.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
To investigate the onset of treatment effects over time observed for liraglutide in combination with oral antidiabetic drugs (OADs).
METHODS
This analysis included patients from three phase 3, 26-week, randomised, double-blind, parallel-group trials. Prior to randomisation, patients
Adding liraglutide to oral antidiabetic drug monotherapy: efficacy and weight benefits.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
To examine the options for add-on therapy in patients with type 2 diabetes whose disease is no longer adequately controlled by lifestyle interventions and oral antidiabetic drug (OAD)monotherapy.
METHODS
This analysis included a subset of patients receiving prior OAD monotherapy from 2
Hypoglycemic encephalopathy mimicking acute ischemic stroke in clinical presentation and magnetic resonance imaging: a case report.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Evaluation of adverse events of oral antihyperglycemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysis.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
To evaluate and compare the risk of adverse events (AEs) associated with the use of metformin, sulfonylureas and thiazolidinediones among geriatric patients in a usual care setting.
METHODS
An electronic medical record database was utilized to identify geriatric patients with type 2
Efficacy and harms of the hypoglycemic agent pramlintide in diabetes mellitus.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE
We conducted a study to examine the efficacy, effectiveness, and harms of pramlintide as adjunct therapy in adults and children with type 1 or type 2 diabetes.
METHODS
We searched multiple bibliographic databases to January 2010, the US Food and Drug Administration Web site, and other
[Exenatid and its position as antidiabetic drug in the treatment of type 2 diabetes mellitus].
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
'Incretin effect' refers to increased insulin response to oral glucose as compared to i.v. glucose response. Incretin mimetics are a new class of antidiabetic drugs lowering hyperglycaemia. Incretin mimetics mimic the natural human hormones called 'incretins' with blood glucose regulating action.
Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) in Japanese patients with type 2 diabetes mellitus inadequately controlled on basal insulin and oral antidiabetic drugs: The LixiLan JP-L Randomized Clinical Trial.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Safety, tolerability and efficacy of lixisenatide in combination with oral antidiabetic treatment in Japanese patients with type 2 diabetes: An open-label, multicenter study.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
UNASSIGNED
To assess the overall safety and efficacy of lixisenatide in combination with background oral antidiabetic drug treatment in Japanese patients with type 2 diabetes, as required by Japanese guidelines.
METHODS
A phase 3, multicenter, uncontrolled, open-label, four-arm, parallel-group study
A 1-year safety study of dulaglutide in Japanese patients with type 2 diabetes on a single oral hypoglycemic agent: an open-label, nonrandomized, phase 3 trial.
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The goal of this study was to assess the safety and efficacy of 0.75 mg of dulaglutide, a once weekly glucagon-like peptide-1 receptor agonist, in Japanese patients with type 2 diabetes (T2D) on a single oral hypoglycemic agent (OHA). In this phase 3, nonrandomized, open-label, parallel-group,
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
